Hims & Hers Health, Inc. is facing scrutiny from regulators, payment networks and investor attorneys after a July 29, 2026 Federal Trade Commission lawsuit and an August 21 report that Visa placed the company on notice over customer complaints. The FTC accused Hims & Hers of sharing customers' medical information with third-party advertisers, including Snap and Meta Platforms, the parent of Facebook, describing the alleged conduct as "deceptive and unlawful privacy practices." Hims shares fell $4.32, or 14.73%, to close at $25 on July 29. Bloomberg later reported that Visa enrolled the company in its Acquirer Monitoring Program after a surge in credit-card disputes tied to its weight-loss subscription business. The reported disputes were expected to generate an $8 surcharge each and a bill of nearly $75,000 in September; Hims shares fell as much as $2.70, or 7.99%, to close at $31.08 on Aug. 24. The Law Offices of Howard G. Smith is investigating potential federal securities-law violations on behalf of investors who suffered losses. Kessler Topaz Meltzer & Check, LLP had separately announced an investigation following the FTC lawsuit.